Phenylpropanolamine has been classified by the FDA advisory review panel as generally safe and effective for short-term weight control. The maximum daily dose for this indication is 75 mg. When used in recommended doses by patients without significant risk factors, serious side effects appear to occur infrequently. The pharmacist has an important role in preventing misuse and abuse of phenylpropanolamine through counseling the patient about its appropriate, short-term (not exceeding 12 weeks) use in a comprehensive weight-reduction program. Patients should be alerted to signs and symptoms of serious adverse reactions and advised to discontinue use if any reactions appear.
{"title":"Phenylpropanolamine hydrochloride.","authors":"D. M. Williams","doi":"10.32388/h399zp","DOIUrl":"https://doi.org/10.32388/h399zp","url":null,"abstract":"Phenylpropanolamine has been classified by the FDA advisory review panel as generally safe and effective for short-term weight control. The maximum daily dose for this indication is 75 mg. When used in recommended doses by patients without significant risk factors, serious side effects appear to occur infrequently. The pharmacist has an important role in preventing misuse and abuse of phenylpropanolamine through counseling the patient about its appropriate, short-term (not exceeding 12 weeks) use in a comprehensive weight-reduction program. Patients should be alerted to signs and symptoms of serious adverse reactions and advised to discontinue use if any reactions appear.","PeriodicalId":75481,"journal":{"name":"American pharmacy","volume":"NS30 10 1","pages":"47-50"},"PeriodicalIF":0.0,"publicationDate":"2020-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44423724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Severe disease — Patients with severe ulcerative colitis usually have a large region of the colon involved, often the entire colon. Symptoms of severe ulcerative colitis include Diagram of the colon and rectum Ulcerative Colitis (UC) is a disease in which the lining of the colon (the large intestine) becomes inflamed. The immune system mistakenly targets the lining of the colon, causing inflammation, ulceration, bleeding and diarrhea. The inflammation almost always affects the rectum and lower part of the colon, but it can also effect the entire colon
{"title":"Ulcerative colitis.","authors":"G. Lieberman","doi":"10.32388/mvrgf3","DOIUrl":"https://doi.org/10.32388/mvrgf3","url":null,"abstract":"Severe disease — Patients with severe ulcerative colitis usually have a large region of the colon involved, often the entire colon. Symptoms of severe ulcerative colitis include Diagram of the colon and rectum Ulcerative Colitis (UC) is a disease in which the lining of the colon (the large intestine) becomes inflamed. The immune system mistakenly targets the lining of the colon, causing inflammation, ulceration, bleeding and diarrhea. The inflammation almost always affects the rectum and lower part of the colon, but it can also effect the entire colon","PeriodicalId":75481,"journal":{"name":"American pharmacy","volume":"NS32 8 1","pages":"27"},"PeriodicalIF":0.0,"publicationDate":"2020-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49083400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-01DOI: 10.1093/med/9780198795551.003.0006
D. Semple, R. Smyth
This chapter covers depression. After a historical perspective, it describes the symptoms, caseness, and clinical presentations to aid in diagnosis. Epidemiology and aetiology of the disease are both covered, and specific investigations for diagnosis are outlined. The course and prognosis are discussed, and management principles are covered. Both inpatient and outpatient treatment are covered. Treatment methods for depression both with and without psychotic features are defined, and treatment-resistant depression management is also discussed. Antidepressants, including schedules for swapping or stopping drugs, are covered, including tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), and selective serotonin reuptake inhibitors (SSRIs), as well as assorted other pharmaceutical interventions. Electroconvulsive therapy (ECT) is covered in detail.
{"title":"Depressive illness","authors":"D. Semple, R. Smyth","doi":"10.1093/med/9780198795551.003.0006","DOIUrl":"https://doi.org/10.1093/med/9780198795551.003.0006","url":null,"abstract":"This chapter covers depression. After a historical perspective, it describes the symptoms, caseness, and clinical presentations to aid in diagnosis. Epidemiology and aetiology of the disease are both covered, and specific investigations for diagnosis are outlined. The course and prognosis are discussed, and management principles are covered. Both inpatient and outpatient treatment are covered. Treatment methods for depression both with and without psychotic features are defined, and treatment-resistant depression management is also discussed. Antidepressants, including schedules for swapping or stopping drugs, are covered, including tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), and selective serotonin reuptake inhibitors (SSRIs), as well as assorted other pharmaceutical interventions. Electroconvulsive therapy (ECT) is covered in detail.","PeriodicalId":75481,"journal":{"name":"American pharmacy","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61653127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2003-09-24DOI: 10.1525/california/9780520234017.003.0007
E. Pianka, L. Vitt
{"title":"Reflections on the 'real world'.","authors":"E. Pianka, L. Vitt","doi":"10.1525/california/9780520234017.003.0007","DOIUrl":"https://doi.org/10.1525/california/9780520234017.003.0007","url":null,"abstract":"","PeriodicalId":75481,"journal":{"name":"American pharmacy","volume":"NS35 7 1","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2003-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67126398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Treatment of community-acquired urinary tract infections.","authors":"B E Perdue, K I Plaisance","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75481,"journal":{"name":"American pharmacy","volume":"NS35 12","pages":"37-45"},"PeriodicalIF":0.0,"publicationDate":"1995-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19527225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1995-12-01DOI: 10.1016/S0160-3450(15)30001-5
Nicholas J. Lynn BS Pharm, JD, Robert E. Kamm BS Pharm, JD
{"title":"Exercising professional judgment in such areas as counseling drug product selection raises new liability issues for pharmacists","authors":"Nicholas J. Lynn BS Pharm, JD, Robert E. Kamm BS Pharm, JD","doi":"10.1016/S0160-3450(15)30001-5","DOIUrl":"10.1016/S0160-3450(15)30001-5","url":null,"abstract":"","PeriodicalId":75481,"journal":{"name":"American pharmacy","volume":"35 12","pages":"Pages 14-24"},"PeriodicalIF":0.0,"publicationDate":"1995-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0160-3450(15)30001-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"55872475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A disguised-patient technique was used to study the nature and frequency of dispensing errors and quality of patient medication counseling in 100 randomly selected community pharmacies. Analysis of 100 prescription orders dispensed detected 24 dispensing errors, of which 4 were clinically significant. Oral counseling was provided to 64 of the patients, covering an average of 3 of the 14 categories of drug information that the Omnibus Budget Reconciliation Act of 1990 (OBRA '90) requires pharmacists to consider when counseling Medicaid patients. In addition to prescriber's label instructions, pharmacists provided written counseling information, including auxiliary labels and receipts, to 98% of the patients, but it covered only an average of six OBRA '90 categories. The results suggest that problems with the quality of community pharmacy medication counseling and dispensing accuracy require immediate attention.
{"title":"Dispensing errors and counseling in community practice.","authors":"E L Allan, K N Barker, M J Malloy, W M Heller","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A disguised-patient technique was used to study the nature and frequency of dispensing errors and quality of patient medication counseling in 100 randomly selected community pharmacies. Analysis of 100 prescription orders dispensed detected 24 dispensing errors, of which 4 were clinically significant. Oral counseling was provided to 64 of the patients, covering an average of 3 of the 14 categories of drug information that the Omnibus Budget Reconciliation Act of 1990 (OBRA '90) requires pharmacists to consider when counseling Medicaid patients. In addition to prescriber's label instructions, pharmacists provided written counseling information, including auxiliary labels and receipts, to 98% of the patients, but it covered only an average of six OBRA '90 categories. The results suggest that problems with the quality of community pharmacy medication counseling and dispensing accuracy require immediate attention.</p>","PeriodicalId":75481,"journal":{"name":"American pharmacy","volume":"NS35 12","pages":"25-33"},"PeriodicalIF":0.0,"publicationDate":"1995-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19527223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：